MSLE
Satellos Bioscience Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$140.61M
P/E Ratio
—
EPS
$-1.79
Beta
1.19
52W High
$13.39
52W Low
$4.52
50-Day MA
$7.15
200-Day MA
$7.27
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Satellos Bioscience Inc. Common Stock
Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company is headquartered in Toronto, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-4.28M |
| EBITDA | $-30.02M |
| Operating Margin | 0.00% |
| Return on Equity | -50.70% |
| Return on Assets | -31.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.83 |
| Price-to-Book | 1.99 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 4.75 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $20.83M |
| Float | $17.66M |
| % Insiders | 6.49% |
| % Institutions | 42.35% |
Historical Volatility
HV 10-Day
51.08%
HV 20-Day
76.51%
HV 30-Day
97.06%
HV 60-Day
104.20%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($27.67 target)
4
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026